Banka BioLoo DuPont analysis

·UnclassifiedChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−1.42×−1.34×0.97×1.24×0.70×
−0.07×−0.12×1.69×−0.38×0.81×
6.4%4.2%−10.0%2.9%10.5%
0.62×0.62×0.68×0.70×0.65×
2.37×2.37×2.60×1.95×1.63×
0.9%1.0%−29.1%−1.8%6.3%
1.0%1.0%−25.0%−1.2%6.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BANKA₹65.00

Banka BioLoo Limited

· Unclassified
₹ CrorePeersRAJMETAAKASHGLOBEGRADIENTEMOKSHARTNIRMANAJOONIBEARDSELLMcap ₹71 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.701.240.97-1.34-1.42
Interest Burden (Pretax/EBIT) ×0.81-0.381.69-0.12-0.07
EBIT Margin %10.542.88-9.974.206.42
Asset Turnover ×0.650.700.680.620.62
Financial Leverage (Assets/Equity) ×1.631.952.602.372.37
ROE (5-step product, year-end total equity) %6.34-1.83-29.091.010.91
ROE (owners' profit / average owners' equity) %6.33-1.24-25.010.990.99
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.